NIH Guide for Grants and Contracts
February 07, 2020
Weekly NIH Funding Opportunities and Notices

Policy Notices

General Notices

Notice of Changes to Funding Opportunities

Notices of Special Interest

Funding Opportunities

  • Non-Viral Technologies for in vivo Delivery of Genome Editors (R43/R44 Clinical Trial Not Allowed)
    (PAR-20-098)
    National Center for Advancing Translational Sciences
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute of General Medical Sciences
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): Standard dates apply The first standard due date for this FOA is April 5, 2020

  • Biomedical Technology Development and Dissemination Center (RM1 - Clinical Trial Not Allowed)
    (PAR-20-104)
    National Institute of General Medical Sciences
    Application Receipt Date(s): May 26, 2020; January 26, 2021; May 26, 2021; January 26, 2022; May 26, 2022; January 26, 2023

  • Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed
    (PAR-20-105)
    Food and Drug Administration
    Application Receipt Date(s): May 6, 2020 by 11:59 PM Eastern Time April 6, 2021 by 11:59 PM Eastern Time. April 6, 2022 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.

  • Centers for AIDS Research (P30 Clinical Trial Not Allowed)
    (PAR-20-106)
    National Institute of Allergy and Infectious Diseases
    John E. Fogarty International Center
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities
    National Institute of Nursing Research
    Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.

  • Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)
    (PAR-20-107)
    National Institute of Allergy and Infectious Diseases
    John E. Fogarty International Center
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities
    National Institute of Nursing Research
    Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.

  • International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
    (PAR-20-108)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): July 15, 2020; July 15, 2021; July 15 2022

  • Non-Viral Technologies for in vivo Delivery of Genome Editors (R41/R42 Clinical Trial Not Allowed)
    (PAR-20-109)
    National Center for Advancing Translational Sciences
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute of General Medical Sciences
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): Standard dates apply The first standard due date for this FOA is April 5, 2020

  • National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (U24 Clinical Trial Not Allowed)
    (PAR-20-110)
    National Institute on Aging
    Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is May 25, 2020.

  • Molecular Mechanisms of Combination Adjuvants (MMCA) (U01 Clinical Trial Not Allowed)
    (RFA-AI-20-004)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): July 20, 2020

  • Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)
    (RFA-OD-20-008)
    Office of Disease Prevention
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Drug Abuse
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): July 8, 2020, February 08, 2021, October 08, 2021, July 8, 2022) All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)
    (RFA-OD-20-009)
    Office of Disease Prevention
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Drug Abuse
    National Institute of Environmental Health Sciences
    Application Receipt Date(s): July 8, 2020, February 08, 2021, October 08, 2021, July 8, 2022 Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required)
    (RFA-OD-20-010)
    Office of Disease Prevention
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Drug Abuse
    Application Receipt Date(s): July 8, 2020, February 08, 2021, October 08, 2021, July 8, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

  • Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Required)
    (RFA-OD-20-011)
    Office of Disease Prevention
    National Cancer Institute
    National Heart, Lung, and Blood Institute
    National Institute on Drug Abuse
    Application Receipt Date(s): July 8, 2020, February 08, 2021, October 08, 2021, July 8, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applications are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.